Hims & Hers Health reported fourth-quarter results on Monday that beat analysts’ expectations, but the stock sank in extended trading.
Related Posts
The crazy ride in quantum computing stocks continues as shares rip higher on Microsoft’s ‘quantum ready’ directive
Quantum computing stocks rallied Wednesday after Microsoft urged businesses to get “quantum-ready” in 2025.
Walmart, Palantir and inflation concerns: What investors think was behind Thursday’s sell-off
Thursday saw a broad sell-off across the three major stock market averages, and some strategists and investors analyzed what could have caused the move.
S&P 500 futures fall from record as Nvidia declines following earnings: Live updates
Investors weighed Nvidia’s latest quarterly results.